Pharmacy Practice
Affordable Medicines
Biosimilars
Compliance
Compounding
Drug Approvals
Geriatrics
Hospital/Health System
In-Pharmacy Vaccines
Law
Medication Management
News & Trends
OTC
Pharmacist Resources
Specialty Pharmacy
Technology
Disease State
Allergy
Autoimmune
Breast Cancer
Cardiovascular
Cold & Flu
COVID-19
Dermatology
Diabetes
Gastroenterology
Hematology
HIV/AIDS
Infectious Disease
Infusion
Lung Cancer
Mental Health
mRNA Technology
Neurology
Oncology
Ophthalmology
Orthopedics
Pain Management
Pediatrics
Respiratory
Schizophrenia
Urology/Nephrology
Women’s Health
Health Awareness Month
Videos
Patient Teaching Aid
Publications
Featured Issue
Featured Supplements
Conference Coverage
Continuing Education
Subscribe
COVID-19 Resources
Biosimilars
December 19, 2023
Savings From Adalimumab Biosimilar Use in Various Countries
December 19, 2023
Cost-Effectiveness of SC Versus IV Trastuzumab
December 19, 2023
Safety Outcome Variances Between Reference Products, Biosimilars
November 17, 2023
Clinical Similarity Between Reference Products, Biosimilars
November 17, 2023
Bevacizumab Biosimilars Provide Savings, Comparable Survival Benefits
November 17, 2023
Benefits of Oncology Biosimilars in China, Other Countries
October 17, 2023
Biosimilars Lower Healthcare Costs for Patients With Medicare
October 17, 2023
Biosimilar Substitution Resulted in Significant Oncology Cost Savings
October 17, 2023
Abrilada Obtains FDA Approval as Interchangeable Humira Biosimilar
September 14, 2023
Review Explores Patient Opinions About Biosimilars
September 14, 2023
Exploring Gaps, Challenges in Assessing Biosimilars’ Value
September 14, 2023
Study Compares Biosimilars With Their Reference Products
August 15, 2023
Survey Explores Patient Knowledge About Biosimilars
Load More
X
March 2024
In This Issue
Digital Magazine
Archives
Subscription
Related CE
$6.97 Per CE Exam or $59 for 12 Lessons
Spearheading the Implementation of a Biosimilar Program: The Pharmacist’s Role
×
Full Image